news roundup
The merger of INC Research and inVentiv Health will make the unified entity a top three global CRO and a leading CCO comprised of 22,000 employees, in more than 60 countries. Current INC CEO Alistair Macdonald will serve as CEO of the combined company, Greg Rush as Chief Financial Officer and Michael Bell as Executive Chairman.
| advertisment
Security Risks You Should Absolutely Know About When Accessing Trial Data via a Mobile Device
Investigator sites, CROs, central labs, and many others are now accessing trial data and applications via mobile devices. At the same time, healthcare institutions have become a target for cybercriminals. Get to know the security risks, as well as, the best ways to protect your information when using mobile devices.  Read now. |
After announcing it had acquired global patient recruitment firm ThreeWire two weeks ago, WIRB-Copernicus Group acquired eSource provider MedAvante and specialty services provider ProPhase, in a move to offer improved study start-up. Jeffrey Litwin, MD, was named CEO of the newly combined entity. Dr. Litwin is a member of Applied Clinical Trials Editorial Advisory Board.
| advertisment
Talking the Patients' Language – the importance of effective, patient-centered engagement
Live Webinar: Tuesday, June 6 at 8:00am EDT  Register now |
ERT announced the acquisition of ImageIQ, the cloud-based imaging technology invented at Cleveland Clinic. At the core of this technology is the ability to capture high quality, compliant data without the dependency on human intervention and bias, according to ERT.
Articles
The authors of this article raise the issue of traceability of biospecimens that are used by scientists in their studies, which can be pivotal for publishing or filing. When biospecimens are collected as part of clinical trials on drugs, the traceability of all samples is guaranteed by the regulations that govern clinical trials (e.g., GCP guidelines).
Contrary to popular belief, the research nurse is not an isolated contractor performing services remotely, but an integral part of the study team. |
|
